{"transactions":[{"id":2095813,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-05T21:23:13.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Company Options (as defined in the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. (\"Rocket\") and the other parties thereto (the \"Merger Agreement\")), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1224116/000106299322023385/form4.xml","form_type":"4"}},{"id":2095812,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-05T21:23:13.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Company Options (as defined in the Agreement and Plan of Merger, dated as of September 19, 2022, by and among the Issuer, Rocket Pharmaceuticals, Inc. (\"Rocket\") and the other parties thereto (the \"Merger Agreement\")), whether vested or unvested, that were assumed by Rocket in the merger and replaced with an option to purchase a number of Rocket common stock equal to the product of (A) the number of Issuer shares subject to such Company Option as of immediately prior to the First Effective Time (as defined in the Merger Agreement), multiplied by (B) the Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of Rocket common stock, at an exercise price per Rocket common stock underlying such option equal to the quotient obtained by dividing (x) the per share exercise price of Company Options immediately prior to the First Effective Time by (y) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Company Option described herein shall be subject to the same terms and conditions as applied to the corresponding Company Option as of immediately prior to the First Effective Time, except as otherwise provided in the Merger Agreement."}],"balance_after":0,"derivative":{"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001062993-22-023385","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224116/000106299322023385/form4.xml","form_type":"4"}},{"id":2253011,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T16:05:21.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) May 25, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":12000,"derivative":{"exercise_price":1.94,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-013697","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224116/000106299322013697/form4.xml","form_type":"4"}},{"id":2575776,"issuer":{"id":114644,"kind":"organization","name":"Renovacor, Inc.","symbol":"RCOR"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2021-09-08T19:03:18.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest and become exercisable 25% on the first anniversary of the grant and the remainder will vest and become exercisable in 36 equal monthly installments on the 3rd of each month for the remaining 36 months, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":24000,"derivative":{"exercise_price":7.73,"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001192482-21-000715","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224116/000119248221000715/edgar.xml","form_type":"4"}},{"id":2976131,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-18T23:06:33.000Z","date":"2020-11-16","kind":"grant","acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Plan will vest on the first anniversary of the Grant Date, and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":8200,"derivative":{"exercise_price":90.65,"expiration_date":"2030-11-16","underlying":"Common Stock","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001209191-20-059194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120059194/doc4.xml","form_type":"4"}},{"id":2976130,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-18T23:06:33.000Z","date":"2020-11-16","kind":"grant","acquired":true,"shares":7300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on each of the first three (3) anniversaries of the November 16, 2020 grant date (the \"Grant Date\"), subject to continued employment through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on each of the first three (3) anniversaries of the November 16, 2020 grant date (the \"Grant Date\"), subject to continued employment through each such vesting date."}],"balance_after":7300,"derivative":{"underlying":"Common Stock","underlying_shares":7300},"source":{"system":"sec-edgar","filing":"0001209191-20-059194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120059194/doc4.xml","form_type":"4"}},{"id":3690651,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO, PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-22T09:56:19.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":29509,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option."}],"balance_after":0,"derivative":{"exercise_price":40.55,"expiration_date":"2028-07-16","underlying":"Common Stock","underlying_shares":29509},"source":{"system":"sec-edgar","filing":"0001123292-19-000165","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000165/edgar.xml","form_type":"4"}},{"id":3690650,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO, PAO"}}],"security":"Restricted Stock Units","published_at":"2019-01-22T09:56:19.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":17174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17174},"source":{"system":"sec-edgar","filing":"0001123292-19-000165","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000165/edgar.xml","form_type":"4"}},{"id":3690649,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO, PAO"}}],"security":"Restricted Stock Units","published_at":"2019-01-22T09:56:19.000Z","date":"2019-01-22","kind":"disposition_to_issuer","acquired":false,"shares":1525,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of TESARO common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the \"Effective Time\") in exchange for a cash payment of $75.00 per share."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001123292-19-000165","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000165/edgar.xml","form_type":"4"}},{"id":3690648,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO, PAO"}}],"security":"Common Stock","published_at":"2019-01-22T09:56:19.000Z","date":"2019-01-22","kind":"other","acquired":false,"shares":2156,"price":75,"value":161700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation (\"Purchaser\") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales (\"Parent\"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation (\"TESARO\"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-19-000165","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000112329219000165/edgar.xml","form_type":"4"}},{"id":3721285,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CAO,PAO"}}],"security":"Restricted Stock Units","published_at":"2018-12-21T19:18:04.000Z","date":"2018-12-20","kind":"exercise","acquired":false,"shares":3055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represented a contingent right to receive one share of TESARO common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 20, 2018, the Compensation Committee of the Board of Directors of TESARO accelerated the vesting of a portion of the restricted stock units, which were previously scheduled to vest on July 16, 2020. The remaining restricted stock units will vest on July 16, 2020 in accordance with the original vesting schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 20, 2018, the Compensation Committee of the Board of Directors of TESARO accelerated the vesting of a portion of the restricted stock units, which were previously scheduled to vest on July 16, 2020. The remaining restricted stock units will vest on July 16, 2020 in accordance with the original vesting schedule."}],"balance_after":1525,"derivative":{"underlying":"Common Stock","underlying_shares":3055},"source":{"system":"sec-edgar","filing":"0001104659-18-074521","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918074521/a4.xml","form_type":"4"}},{"id":3721284,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CAO,PAO"}}],"security":"Common Stock","published_at":"2018-12-21T19:18:04.000Z","date":"2018-12-20","kind":"tax_withholding","acquired":false,"shares":899,"price":73.1,"value":65716.9,"ownership":{"direct":true},"balance_after":2156,"source":{"system":"sec-edgar","filing":"0001104659-18-074521","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918074521/a4.xml","form_type":"4"}},{"id":3721283,"issuer":{"id":160894,"kind":"organization","name":"TESARO, Inc.","symbol":"TSRO"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,CAO,PAO"}}],"security":"Common Stock","published_at":"2018-12-21T19:18:04.000Z","date":"2018-12-20","kind":"exercise","acquired":true,"shares":3055,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3055,"source":{"system":"sec-edgar","filing":"0001104659-18-074521","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491576/000110465918074521/a4.xml","form_type":"4"}},{"id":4017541,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-05T21:35:11.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 03/01/2018."}],"balance_after":531,"derivative":{"exercise_price":0,"expiration_date":"2021-03-01","underlying":"Common Stock","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001127602-18-010078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218010078/form4.xml","form_type":"4"}},{"id":4031799,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-27T23:24:23.000Z","date":"2018-02-23","kind":"other","acquired":false,"shares":116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2018-02-23","underlying":"Common Stock","underlying_shares":116},"source":{"system":"sec-edgar","filing":"0001127602-18-008813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008813/form4.xml","form_type":"4"}},{"id":4031798,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-27T23:24:23.000Z","date":"2018-02-23","kind":"exercise","acquired":false,"shares":92,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":116,"derivative":{"exercise_price":0,"expiration_date":"2018-02-23","underlying":"Common Stock","underlying_shares":92},"source":{"system":"sec-edgar","filing":"0001127602-18-008813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008813/form4.xml","form_type":"4"}},{"id":4031797,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-27T23:24:23.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":28,"price":292.78,"value":8197.84,"ownership":{"direct":true},"balance_after":4744.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-008813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008813/form4.xml","form_type":"4"}},{"id":4031796,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-27T23:24:23.000Z","date":"2018-02-23","kind":"exercise","acquired":true,"shares":92,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4772.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-008813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008813/form4.xml","form_type":"4"}},{"id":4035292,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-26T21:11:36.000Z","date":"2018-02-22","kind":"other","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":302,"derivative":{"exercise_price":0,"expiration_date":"2019-02-22","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001127602-18-008404","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008404/form4.xml","form_type":"4"}},{"id":4035291,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-26T21:11:36.000Z","date":"2018-02-22","kind":"exercise","acquired":false,"shares":194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":402,"derivative":{"exercise_price":0,"expiration_date":"2019-02-22","underlying":"Common Stock","underlying_shares":194},"source":{"system":"sec-edgar","filing":"0001127602-18-008404","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008404/form4.xml","form_type":"4"}},{"id":4035290,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-26T21:11:36.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":58,"price":284.81,"value":16518.98,"ownership":{"direct":true},"balance_after":4680.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-008404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008404/form4.xml","form_type":"4"}},{"id":4035289,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-26T21:11:36.000Z","date":"2018-02-22","kind":"exercise","acquired":true,"shares":194,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4738.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-008404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218008404/form4.xml","form_type":"4"}},{"id":4049455,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-20T21:18:57.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":95,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":514,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":95},"source":{"system":"sec-edgar","filing":"0001127602-18-007189","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007189/form4.xml","form_type":"4"}},{"id":4049454,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-20T21:18:57.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":609,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":161},"source":{"system":"sec-edgar","filing":"0001127602-18-007189","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007189/form4.xml","form_type":"4"}},{"id":4049453,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-20T21:18:57.000Z","date":"2018-02-15","kind":"tax_withholding","acquired":false,"shares":56,"price":299.38,"value":16765.28,"ownership":{"direct":true},"balance_after":4544.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-007189","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007189/form4.xml","form_type":"4"}},{"id":4049452,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2018-02-20T21:18:57.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4600.3601,"source":{"system":"sec-edgar","filing":"0001127602-18-007189","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218007189/form4.xml","form_type":"4"}},{"id":4060779,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-14T23:42:39.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":1390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1390,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1390},"source":{"system":"sec-edgar","filing":"0001127602-18-006187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218006187/form4.xml","form_type":"4"}},{"id":4060778,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-14T23:42:39.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units will vest in 2 annual installments.  One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date."}],"balance_after":345,"derivative":{"exercise_price":0,"expiration_date":"2020-02-12","underlying":"Common Stock","underlying_shares":345},"source":{"system":"sec-edgar","filing":"0001127602-18-006187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218006187/form4.xml","form_type":"4"}},{"id":4143216,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-12-05T21:36:16.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":103,"price":319.35,"value":32893.05,"ownership":{"direct":true},"balance_after":4439.3601,"source":{"system":"sec-edgar","filing":"0001127602-17-033936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033936/form4.xml","form_type":"4"}},{"id":4143215,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-12-05T21:36:16.000Z","date":"2017-12-01","kind":"tax_withholding","acquired":false,"shares":54,"price":319.35,"value":17244.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 86.155 shares and 5.382 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2017 and 6/30/2017, respectively."}],"balance_after":4542.3601,"source":{"system":"sec-edgar","filing":"0001127602-17-033936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033936/form4.xml","form_type":"4"}},{"id":4411700,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."},{"field":"shares","element":"transactionShares","label":"F11","text":"This award was previously reported as covering 258 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F11","text":"This award was previously reported as covering 258 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F11","text":"This award was previously reported as covering 258 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2017-02-12","underlying":"Common Stock","underlying_shares":121},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411699,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."},{"field":"shares","element":"transactionShares","label":"F9","text":"This award was previously reported as covering 315 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout.  One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"This award was previously reported as covering 315 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"This award was previously reported as covering 315 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2017-02-12","underlying":"Common Stock","underlying_shares":321},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411698,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."},{"field":"shares","element":"transactionShares","label":"F8","text":"This award was previously reported as covering 870 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"This award was previously reported as covering 870 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"This award was previously reported as covering 870 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"}],"balance_after":596,"derivative":{"exercise_price":0,"expiration_date":"2019-02-22","underlying":"Common Stock","underlying_shares":163},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411697,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."},{"field":"shares","element":"transactionShares","label":"F7","text":"This award was previously reported as covering 402 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"This award was previously reported as covering 402 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"This award was previously reported as covering 402 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017"}],"balance_after":208,"derivative":{"exercise_price":0,"expiration_date":"2018-02-23","underlying":"Common Stock","underlying_shares":76},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411696,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"other","acquired":false,"shares":128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":284,"derivative":{"exercise_price":0,"expiration_date":"2018-02-23","underlying":"Common Stock","underlying_shares":128},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411695,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"other","acquired":false,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":759,"derivative":{"exercise_price":0,"expiration_date":"2019-02-22","underlying":"Common Stock","underlying_shares":131},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411694,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"other","acquired":false,"shares":143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":121,"derivative":{"exercise_price":0,"expiration_date":"2017-02-12","underlying":"Common Stock","underlying_shares":143},"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411693,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":3,"price":274.76,"value":824.28,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4504.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411692,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4507.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411691,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":8,"price":274.76,"value":2198.08,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4386.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411690,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"This award vested on 2/12/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4394.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411689,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":53,"price":287.63,"value":15244.39,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4073.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411688,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":4126.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411687,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":25,"price":284.75,"value":7118.75,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":3963.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4411686,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2017-03-02T22:18:20.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award.  Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017.  Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017."}],"balance_after":3988.8231,"source":{"system":"sec-edgar","filing":"0001127602-17-009812","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217009812/form4.xml","form_type":"4"}},{"id":4440896,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-02-18T01:24:03.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":770,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":770},"source":{"system":"sec-edgar","filing":"0001127602-17-007113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217007113/form4.xml","form_type":"4"}},{"id":4534204,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2016-12-05T21:32:24.000Z","date":"2016-12-01","kind":"tax_withholding","acquired":false,"shares":53,"price":295.78,"value":15676.34,"ownership":{"direct":true},"balance_after":3883.8231,"source":{"system":"sec-edgar","filing":"0001127602-16-069149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760216069149/form4.xml","form_type":"4"}},{"id":4534203,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":121855,"kind":"person","name":"COVINO GREGORY F","position":1,"cik":"0001224116","reported_name":"COVINO GREGORY F","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2016-12-05T21:32:24.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":930,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3936.8231,"source":{"system":"sec-edgar","filing":"0001127602-16-069149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760216069149/form4.xml","form_type":"4"}}]}